ACRF Accelerate

ACRF Australian Centre of Excellence in Melanoma
Imaging & Diagnosis. Revolutionising the early
detection of melanoma.


Despite sun safety messages, melanoma rates are growing in Australia, with the deadly disease killing more Australians each year than road accidents. Melanoma is the most dangerous form of skin cancer because if it isn’t detected early, it can spread to other organs. For that reason, early diagnosis is key to survival. While an individual with Stage 1 melanoma has a 99% chance of surviving longer than 5 years, that figure drops dramatically if the cancer spreads. Individuals with Stage 4 melanoma have just a 20% chance of surviving longer than 5 years.

The ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis aims to reduce the annual melanoma death toll by using sophisticated 3D imaging systems to produce whole-body scans that can be monitored over time. These scans create patient ‘avatars’, enabling melanoma to be detected earlier. Within 3 years, the project database of 100,000 avatars
will be the largest in the world. The roll-out of 15 imaging systems will allow specialist doctors to view a patient’s scans from any location, helping patients in rural and remote areas who may not have access to specialist care.

ACRF Accelerate

Are you interested in finding out more about this world-first clinical trial?

The ACEMID team will be running a number of clinical trials using the Vectra 3D Skin Imaging Systems in Queensland, New South Wales and Victoria. If you would like to be involved in future studies you can find access to the Expression of Interest forms via the link below.

ACRF ACEMID facilitation:

  • World-class research expertise to provide new solutions for the early diagnosis of melanoma.
  • More equitable access to melanoma diagnosis in regional Australia.
  • Telemedicine supported by Artificial Intelligence (AI).
  • World’s largest research repository of 3D total body skin images

ACRF is proud to support this pioneering program to tackle Australia’s national cancer.  ACRF funds the technology, equipment and infrastructure that powers lifesaving cancer research.

We acknowledge the research contributions, clinical partnerships, complementary support and health e-initatives from all collaborative partners involved in ACEMID.

The centre will see 15 sites across Australia with plans to include the following locations:


  • Princess Alexandra Hospital (Pilot site already exists, will be joined to ACRF network)
  • Cairns
  • Sunshine Coast
  • Royal Brisbane Women’s Hospital
  • Townsville
  • Mt Isa

New South Wales

  • Westmead Hospital
  • Melanoma Institute Australia
  • Royal Prince Alfred Hospital
  • Dubbo
  • Port Macquarie/Coffs Harbour


  • The Alfred Hospital
  • Skin Health Institute
  • Bendigo Health
  • Peter MacCallum Cancer Centre
  • Bass Coast Health, Wonthaggi